CD274 and neoplasm: In NCT06481592, researchers aim to study the efficacy and safety of Lifileucel (tumor-infiltrating lymphocytes) in advanced EC patients who have previously received treatment with platinum-based chemotherapy and an anti-PD-1/PD-L1 agent in a recurrent or advanced setting, either sequentially or in combination.